No Data
No Data
Donga Ejiao (000423): 1Q24 results are in line with expectations and the first mid-term dividend in history was launched
1Q24 results are in line with our expectations. The company announced 1Q24 results: revenue of 1,453 billion yuan, up 35.95% year on year; net profit to mother of 353 million yuan, up 53.43% year on year; net profit of 3.29 million yuan
Donga Ejiao (000423): Continued high growth rate in the first quarter and launched mid-term dividends for the first time
Key investment points: First-quarter results continued to grow at a high rate. Expense ratio optimization Q24: The company achieved revenue of 1.45 billion yuan, an increase of 36%; net profit to mother of 350 million yuan, an increase of 53%; net profit after deducting non-return to mother of 330 million
Dong'e Ejiao (000423): Full launch
1Q24 revenue and non-net profit increased 36% year-on-year, 55%. The company announced 1Q24 revenue of 1.45 billion yuan, net profit to mother of 350 million yuan, and deducted non-net profit of 330 million yuan (year-on-year increase of 36%, 53%, 55%)
China Resources Pharmaceutical (03320.HK): Donga Ejiao's net profit of 353 million yuan in the first quarter increased 53.43% year-on-year
Gelonghui, April 26 | China Resources Pharmaceutical (03320.HK) announced that Donga Ejiao (000423.SZ)'s revenue for the first quarter of 2024 was 1,453 billion yuan, up 35.95% year on year; net profit attributable to shareholders of listed companies (Donga Ejiao) was 353 million yuan, up 53.43% year on year; net profit attributable to shareholders of listed companies (Donga Ejiao) after deducting non-recurring profit and loss was 329 million yuan, up 54.79% year on year; basic earnings per share were 0.5488 yuan.
Express News | Donga Ejiao: Net profit of 353 million yuan in the first quarter, an increase of 53.43% year-on-year
Huafu Securities released a research report on April 21 stating that Donga Ejiao (000423.SZ) was given a holding rating, and the target price was 75.56 yuan. The main reasons for the rating include: 1) building a leader in the tonic industry and building
Huafu Securities released a research report on April 21 stating that Donga Ejiao (000423.SZ) was given a holding rating, and the target price was 75.56 yuan. The main reasons for the rating include: 1) building a leader in the tonic industry and building a “pharmaceutical+health consumer goods” two-wheel drive; 2) clearing product inventory with the aim of stabilizing the relationship between supply and demand and volume and price; 3) equity incentives highlight the company's confidence in development. (Mainichi Keizai Shimbun)
No Data